Prof. dr. J.Fink-Gremmels DVM, PhD, Dip ECVPT President EAVPT 22-04-2015 MP-EU EPP: Antimicrobial resistance: urgent need to act in human.

Slides:



Advertisements
Similar presentations
Global Health Security Agenda Bureau of Epidemiology, Department of Disease Control A threat anywhere is a threat everywhere.
Advertisements

European Antibiotic Awareness Day 2013, 18 November 2013 European Antibiotic Awareness Day 2013 * Joining efforts to avoid a post-antibiotic era [Name.
More proven interventions are available to prevent and treat diarrhea than any other major child killer Jones G Bryce J. et al. Lancet UNICEF. Diarrhoea:
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
TRAINING FOR ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN HOSPITALS JUNE 2014.
International Epidemics Lecture September 23, 2014 B.W. Cue, Jr. (UMB 1969) Outline – An overview of infectious microbes (excluding fungii) Bacterial vs.
Antimicrobial resistance “One health fits all”
University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Romania Since 1869 Anti-microbial resistance – Urgent need to act in human and.
Co-operation on Health and Biodiversity IUFRO Forests and Health Seminar, Marrakesh, Morocco, 30 th April 2008.
Nature Creates – We Refine Nature creates – we refine.
Lesson 3 Good Production Practice #3 Use Antibiotics Responsibly.
Essential Drugs Programme
31.4 Immunity and Technology
7 1 FVE General Assembly Agenda point 10: EU Community Animal Health Strategy Brussels, 16 November 2007.
TBS November 4, |1 | AMR and appropriate use of antimicrobials Nicola Magrini and Jane Robertson Policy, Access and Use Team, EMP TBS 4 November.
Module 5 Emergencies and the Health Systems. Module 5 Hospital System Health System Epidemiology and Surveillance Prevention and Control of Communicable.
Global and National Response to AMR Chatham House/Murdoch University AMR Symposium Chris Baggoley 8 December 2014.
Importance of vaccines. | Onderstepoort Biological Products © |22nd February 2013Page 15.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
Veterinary Medicine in Knowledge based Society Stiftung Tierärztliche Hochschule Hannover.
Antibody concentration
ANTIBIOTIC RESISTANCE
Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,
VIRUSES Tobacco mosaic virus Influenza virus Adenovirus Bacteriophage.
ANTIGEN ANTIBODY Proteins that recognize and bind to antigens.
Many methods are used to control pathogens.
31.4 Immunity and Technology Living in a clean environment and building immunity help keep a person healthy.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.
Integrating Public Health and Adaptation Kristie L. Ebi, Ph.D., MPH Cities at Risk 28 February 2009.
Pathogen Epidemic & Pandemic Test Review. 1) Compare & Contrast Disease Pathogens Please use notes, book, info to complete chart BacteriaVirusParasiteFungus.
Update on Antibiotic Usage in the Pig Sector Caroline Garvan, Veterinary Inspector.
The AMR One Health Policy Toolkit: Animal - Human Interface Dr Mark Schipp December 2014.
Dutch antibiotic resistance policy
Antimicrobial resistance
Holy Family Catholic High School 17th April 2007 Developing medicines + Immunity UNIT 11.4 Controlling infectious disease Form 10 A4.
Perspectives on containing antimicrobial resistance – ways to go … Karl Ekdahl, Strategic Advisor on behalf of Zsuzsanna Jakab, Director European Centre.
How can we prevent the spread of infectious disease? Immunity: body’s ability to destroy pathogen’s before they can cause disease.
Ministerial Declaration and Concluding Remarks MD PhD Karin Tegmark Wisell Chair AMR expert group, NDPHS.
Antibiotic resistance: National actions contribute to a global solution NEPAL Professor Paras K Pokharel Vice Chair GARP Nepal.
Prudent use of antibiotics in the animal sector Lessons from Sweden Jenny Lundstrom, DVM, PhD.
1. SUSTAINABLE ANIMAL PRODUCTION The future of the farmers 2.
Christianne Bruschke Chief Veterinary Officer Ministry of Economic Affairs Taking on Antibiotic Resistance Opportunities to keep antibiotics working for.
Jaap Wagenaar DVM PhD Utrecht University Central Veterinary Institute Veterinary Medicines Authority Christianne Bruschke DVM PhD Chief Veterinary Officer.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
Clostridium difficile Infection Biology & Public Health Impact
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Vaccines.
Responsible Use of Medicines in Agriculture
Work Programme The social challenge “Health, Demographic Change and Wellbeing” Maia Okujava NCP for Health, Demographic Change and weii-being,
ECOANTIBIO Containment of Antimicrobial Resistance (AMR): actions and lessons from the Veterinary Sector in France.
Antiseptics kill pathogens outside of the body.
Jeff Ondrak DVM, MS UNL - GPVEC
Section 31-4 “Immunity-Technology”
Bacteria Virus - Bacteria and viruses may reproduce rapidly inside the body and may produce poisons (toxins) that make us feel ill - Viruses damage the.
Ontario Association of Bovine Practitioners November 6, 2003
The Emma Barnsley Foundation
Many methods are used to control pathogens.
EPRUMA – Part of Responsible Use Declan O’ Brien on behalf of EPRUMA TAIEX, Istanbul, April 19th, 2011.
Many methods are used to control pathogens.
Many methods are used to control pathogens.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
Applications of Biology
Essential Drugs and Medicines Policy
Many methods are used to control pathogens.
Many methods are used to control pathogens.
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Public health measures toward prevention
Essential Drugs and Medicines Policy
The Veterinary position on Responsible Use of Medicines (FVE and WVA)
Many methods are used to control pathogens.
Presentation transcript:

Prof. dr. J.Fink-Gremmels DVM, PhD, Dip ECVPT President EAVPT MP-EU EPP: Antimicrobial resistance: urgent need to act in human & veterinary medicine Implementing the One Health Concept

Medical Faculty Part Veterinay Faculty, Utrecht University Part of Utrecht Life Sciences

The point of departure: the global emergence of AMR Global trade and global mobility have become major drivers of the spread of infectious diseases AND antimicrobial resistance Humans & animals share the same bacteria and often also the same resistance genes Wendlandt et al., 2015

The antibiotic eco-system: need for a multi-actor approach Animal health care Industry Human health care Community & Hospital (ICU) Agriculture FAO-WHO-OIE Tripartite action plan

Antibiotic use in veterinary medicine Raising awareness & implementing the an action plan Human (humane) responsibility for animal health and wellbeing Animal health care & (global) food demands Urgent need to act in veterinary medicine : Enforcement of triple R Reduction – Refinement - Replacement See also EIP-AGRI Focus Groups

The triple R action plan R eduction: The use of antimicrobial as herd managment tools is no longer accepted  Improvement of hygiene programmes  biosecurity  Improvement of disease prevention  vaccination  Improvement of health monitoring & diagnostics (sensor based disease monitoring)  Improvement of immune competence: feed quality – life cycle management Creating Awareness – improving sustainability Action points 1 & 2 FAO/WHO/OIE

In the Netherlands between 2009 (reference) and 2013: a decrease of the antibiotic use by 58% was achieved, with a further decline in 2014 Reduction of antibiotic use (ADD): the primary target The point of concern: Extreme reduction without accompanying measures endangers animal welfare!

The triple R action plan Refinement: Re-evaluating current prescription attitudes Diagnosis-based prescriptions (capacity building) Pathogen-susceptibility testing (rapid diagnostics) Onset of treatment (cure rate) Duration of treatments – need of supportive treatments Ranking of antibiotics (critical important – specialist oversight) Meeting expectations? Expectation of (human) patients Expectations of farmers CONTINUING EDUCATION & COMMUNICATION CAPACITY BUILDING

The gut microbiota are an undesirable target Long persistence in the intestines ….selecting for resistant bacterial populations Impairment of the microbiome results in immune-mediated diseases (allergies, diabetes, inflammatory bowel diseases bacteria; > 500 species 10 x more than body cells Reservoir for resistant bacteria / resistance genes Refinement: Avoidance of collateral damage: Intra-intestinal antibiotics concentrations:

The triple R action plan R eplacement:  Improvement of hygiene programmes  biosecurity  Improvement of disease prevention  vaccination  Improvement of health monitoring & diagnostics  Improvement of immune competence: feed quality – life cycle management Animal health care Starts at the 1 st day of life Chang in mind-set: From Cure to Care

From cure to care: options & opportunities Vaccines (including PNAG-like surface antigen antibodies) Hygiene programs Biosecurity Bacteriophages Peptides Bacteriocines Defensin inducers Killing factors (complement opsonins) non-antibiotic antibacterials (ZnO) Quorum sensing modulators Phytobiotics ProbioticsPrebiotics Improvement of animal health – reduces the need for antibiotics Building strategic cooperation

Food Safety & Food Security One health – our responsibility Thank you!